Skip to main content
ADVANCED SEARCH
Log in
Top
Acta Diabetologica

05-06-2025 | Ketoacidosis | Case Report Free for a limited time

Diabetic ketoacidosis in a patient with type I diabetes treated with tirzepatide

Authors: Ernest Roche, Julie Chapon, Laura Bogenmann, Cédric Luyton, Lucien Marchand

Published in: Acta Diabetologica

Login to get access

Excerpt

A dual glucagon-like peptide 1/gastric inhibitory peptide (GLP-1/GIP) analog, tirzepatide [1], is now available in France for the management of type 2 diabetes, or for weight control (BMI > = 30 kg/m² or > = 27 kg/m² with a comorbidity factor) (but not currently reimbursed by the French health insurance system). …
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Diabetic ketoacidosis in a patient with type I diabetes treated with tirzepatide
Authors
Ernest Roche
Julie Chapon
Laura Bogenmann
Cédric Luyton
Lucien Marchand
Publication date
05-06-2025
Publisher
Springer Milan
Published in
Acta Diabetologica
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-025-02535-x

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits